What’s Happening With PFE Stock?
Pfizer has had its own issues with falling Covid-19 vaccine sales weighing on its stock performance over the recent years.
pharmaphorum23h
Bayer pulls atrial fibrillation study for asundexian
The OCEANIC-AF is comparing asundexian to Pfizer and Bristol-Myers Squibb’s widely-used oral Factor Xa inhibitor Eliquis (apixaban ... the risk of bleeding side effects that make the treatment ...
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
The Root on MSN11h
Stop Listening to These Tired 5 Ozempic, Wegovy Myths And Save Your Health
As the Biden administration is proposing drugs like Ozempic and Wegovy be covered by Medicare and Medicaid, Black people need ...
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Zepbound’s greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of ...
Flow Space on MSN10h
Here's What You Need to Know About GLP-1 Drugs Like Ozempic and Wegovy
GLP-1 receptor agonists, like Ozempic and Wegovy, have been everywhere over the past few years, and research seems to be ...